Meningioma growth during interferon beta-1A treatment for multiple sclerosis.
Gama
Hugo Pereira Pinto
HP
Section of Radiology, Fleury-Diagnostic Center, São Paulo, SP, Brazil.
Rocha
Antônio José da
AJ
Silva
Carlos Jorge
CJ
Mendes
Maria Fernanda
MF
Veiga
José Carlos Esteves
JC
Lancellotti
Carmen Lúcia Penteado
CL
Andrade
Victor Piana
VP
Tilbery
Charles Peter
CP
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000009:adverse effects / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008577:Meningeal Neoplasms / Q000175:diagnosis*; D008579:Meningioma / Q000175:diagnosis*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010982:Platelet-Derived Growth Factor / Q000378:metabolism
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D010982:Platelet-Derived Growth Factor; D016899:Interferon-beta; D000068556:Interferon beta-1a